Dolby Laboratories (NYSE:DLB) CEO Sells 26,766 Shares

by · The Cerbat Gem

Dolby Laboratories (NYSE:DLB – Get Free Report) CEO Kevin Yeaman sold 26,766 shares of the firm’s stock in a transaction that occurred on Tuesday, December 16th. The stock was sold at an average price of $66.74, for a total transaction of $1,786,362.84. Following the completion of the transaction, the chief executive officer directly owned 105,128 shares in the company, valued at $7,016,242.72. This trade represents a 20.29% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Dolby Laboratories Trading Up 0.4%

NYSE:DLB traded up $0.29 during trading hours on Wednesday, hitting $67.09. The company had a trading volume of 575,384 shares, compared to its average volume of 610,696. Dolby Laboratories has a 1 year low of $64.02 and a 1 year high of $89.66. The company has a market cap of $6.41 billion, a P/E ratio of 25.51 and a beta of 0.89. The company has a 50-day moving average of $66.88 and a 200 day moving average of $71.25.

Dolby Laboratories (NYSE:DLB – Get Free Report) last posted its earnings results on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.70 by $0.29. Dolby Laboratories had a net margin of 18.90% and a return on equity of 11.99%. The company had revenue of $307.02 million for the quarter, compared to analyst estimates of $305.76 million. During the same period in the previous year, the business posted $0.61 EPS. Dolby Laboratories’s revenue was up .7% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. On average, analysts forecast that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, December 10th. Investors of record on Tuesday, December 2nd were issued a $0.36 dividend. This is a boost from Dolby Laboratories’s previous quarterly dividend of $0.33. The ex-dividend date was Tuesday, December 2nd. This represents a $1.44 annualized dividend and a yield of 2.1%. Dolby Laboratories’s payout ratio is 54.75%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Baird R W upgraded shares of Dolby Laboratories to a “hold” rating in a research note on Friday, September 5th. Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Monday. Wall Street Zen cut shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, November 22nd. Barrington Research dropped their target price on Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating on the stock in a report on Wednesday, November 19th. Finally, Robert W. Baird began coverage on Dolby Laboratories in a research note on Friday, September 5th. They issued a “neutral” rating and a $74.00 price target on the stock. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Dolby Laboratories currently has a consensus rating of “Moderate Buy” and an average target price of $92.00.

View Our Latest Research Report on Dolby Laboratories

Institutional Investors Weigh In On Dolby Laboratories

A number of institutional investors and hedge funds have recently bought and sold shares of DLB. Norges Bank purchased a new stake in Dolby Laboratories during the 2nd quarter valued at approximately $55,030,000. AQR Capital Management LLC raised its stake in shares of Dolby Laboratories by 51.8% during the 2nd quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock worth $128,935,000 after buying an additional 592,282 shares in the last quarter. Jones Financial Companies Lllp lifted its holdings in shares of Dolby Laboratories by 241,160.1% in the 1st quarter. Jones Financial Companies Lllp now owns 429,443 shares of the electronics maker’s stock valued at $36,975,000 after buying an additional 429,265 shares during the period. First Trust Advisors LP boosted its stake in shares of Dolby Laboratories by 35.2% in the second quarter. First Trust Advisors LP now owns 1,237,443 shares of the electronics maker’s stock valued at $91,893,000 after buying an additional 322,063 shares in the last quarter. Finally, Pacer Advisors Inc. grew its holdings in Dolby Laboratories by 98.2% during the third quarter. Pacer Advisors Inc. now owns 443,897 shares of the electronics maker’s stock worth $32,125,000 after acquiring an additional 219,901 shares during the period. 58.56% of the stock is owned by hedge funds and other institutional investors.

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Read More